Haemonetics Corporation (HAE)

Haemonetics Market Cap

Haemonetics has a market cap or net worth of $4.31 billion as of November 21, 2024. Its market cap has decreased by -3.94% in one year.

• Market Cap: 4.31B
• Enterprise Value: 5.28B
• 1-Year Change: -3.94%
• Ranking: #1427
• Category: Mid-Cap
• Stock Price: $85.85

Market Cap Chart

Since December 1, 1998, Haemonetics's market cap has increased from $605.00M to $4.31B, an increase of 612.68%. That is a compound annual growth rate of 7.85%.

Market Cap History

Date	Market Cap	% Change
Nov 19, 2024	4.26B	-1.81%
Dec 29, 2023	4.34B	9.01%
Dec 30, 2022	3.98B	46.84%
Dec 31, 2021	2.71B	-55.05%
Dec 31, 2020	6.03B	3.54%
Dec 31, 2019	5.82B	12.62%
Dec 31, 2018	5.17B	68.56%
Dec 29, 2017	3.07B	47.73%
Dec 30, 2016	2.08B	26.98%
Dec 31, 2015	1.64B	-14.87%
Dec 31, 2014	1.92B	-11.51%
Dec 31, 2013	2.17B	3.06%
Dec 31, 2012	2.11B	37.73%
Dec 30, 2011	1.53B	-2.18%
Dec 31, 2010	1.56B	10.69%
Dec 31, 2009	1.41B	-1.15%
Dec 31, 2008	1.43B	-10.77%
Dec 31, 2007	1.60B	32.14%
Dec 29, 2006	1.21B	-6.31%
Dec 30, 2005	1.29B	40.58%
Dec 31, 2004	920.10M	59.08%
Dec 31, 2003	578.40M	10.51%
Dec 31, 2002	523.40M	-41.55%
Dec 31, 2001	895.40M	15.08%
Dec 29, 2000	778.10M	26.25%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
ADMA Biologics	4.62B
Biohaven	4.59B
Integer Holdings	4.51B
Axsome Therapeutics	4.48B
Alkermes	4.46B
TG Therapeutics	4.25B
BridgeBio Pharma	4.22B
ICU Medical	4.16B